Skip to main content
  • University of California San Francisco
  • UCSF Health
  • Search UCSF
  • About UCSF
Home

Search form

  • Home
  • Treg Products
  • Clinical Trials
  • People
  • Contact
  • CT group

You are here

Home > Michael Lee

Michael Lee

[email protected]
+1 415 430-7676
Publications: 

Reprogramming human T cell function and specificity with non-viral genome targeting.

Type 1 diabetes immunotherapy using polyclonal regulatory T cells.

Plasticity of human regulatory T cells in healthy subjects and patients with type 1 diabetes.

Human antigen-specific regulatory T cells generated by T cell receptor gene transfer.

Successful clinical islet isolation using a GMP-manufactured collagenase and neutral protease.

T-bet-deficient NOD mice are protected from diabetes due to defects in both T cell and innate immune system function.

Expansion of human regulatory T-cells from patients with type 1 diabetes.

Tyrosine kinase inhibitors reverse type 1 diabetes in nonobese diabetic mice.

CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cells.

 
  • Accessibility
  • Privacy Policy
  • Terms of Use
  • A-Z Website List

© 2025 The Regents of the University of California